Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Other Liabilities

Apellis Pharmaceuticals Inc Other Liabilities Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Other Liabilities from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -57.45% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Other Liabilities for the last 12 months ending December 12, 2018 was $0m a -57.45% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Annual Other Liabilities for 2018 was $0m a -53.85% decrease of 0m from 2017
  • Apellis Pharmaceuticals Inc Annual Other Liabilities for 2017 was $0m
Other Balance Sheet Metrics:
  • Apellis Pharmaceuticals Inc Total Assets for the quarter ending September 09, 2018 was $239m a 23.84% increase of 57m year over year
  • Apellis Pharmaceuticals Inc Total Equity for the quarter ending September 09, 2018 was $196m a 23.99% increase of 47m year over year
View Chart On Koyfin

Quarterly APLS Other Liabilities Data

12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m

Annual APLS Other Liabilities Data

2018$0m
2017$0m